Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 338

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation

Zerr, Danielle M., Corey, Lawrence, Kim, Hyung W., Huang, Meei‐Li, Nguy, Long, Boeckh, Michael·2005·Clinical Infectious Diseases

Abstract

BACKGROUND: Although human herpesvirus 6 (HHV-6) is known to reactivate during hematopoietic stem cell transplantation (HSCT), the clinical significance of this finding is controversial. METHODS: We used a quantitative PCR test for HHV-6 to assay plasma samples prospectively collected from a cohort of 110 allogeneic HSCT recipients to evaluate the clinical effects of HHV-6 infection. A retrospective review of medical records was performed to determine clinical end points. RESULTS: HHV-6 reactivation occurred in 52 (47%) of the 110 subjects. Factors that increased the risk of subsequent HHV-6 reactivation were hematologic malignancy that occurred at a time other than the first remission (adjusted P = .002), a mismatch in the sexes of donor and recipient (adjusted P=.05), younger age (adjusted P = .01), and the receipt of glucocorticoids (adjusted P = .06). HHV-6 reactivation was associated with subsequent all-cause mortality (adjusted hazard ration [HR], 2.9; 95% confidence interval [CI], 1.1-7.5), grade 3-4 graft-versus-host disease (GVHD) (adjusted HR, 4.9; 95% CI, 1.5-16), a lower probability of monocyte engraftment (adjusted HR, 0.42; 95% CI; 0.22-0.80), a lower probability of platelet engraftment (adjusted HR, 0.47; 95% CI, 0.21-1.1; P = .05) and a higher platelet transfusion requirement (adjusted P = .02). A higher level of HHV-6 DNA was associated with subsequent central nervous system (CNS) dysfunction (HR, 21; 95% CI, 1.8-249). CONCLUSIONS: HHV-6 reactivation is common after allogeneic HSCT and is associated with subsequent delayed monocyte and platelet engraftment, increased platelet transfusion requirements, all-cause mortality, grade 3-4 GVHD, and CNS dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/428060

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 11

  1. 10.1016/S0140-6736(88)91883-1 · doi:10.1016/s0140-6736(88)91883-1
  2. Yoshikawa T, 1998, Blood, 92, 2597, 10.1182/blood.V92.7.2597 · doi:10.1182/blood.v92.7.2597
  3. Yoshikawa T, 1991, Blood, 78, 1381, 10.1182/blood.V78.5.1381.1381 · doi:10.1182/blood.v78.5.1381.1381
  4. Drobyski WR, 1993, J Infect Dis, 167, 735, 10.1093/infdis/167.3.735 · doi:10.1093/infdis/167.3.735
  5. 10.1182/blood-2003-05-1597 · doi:10.1182/blood-2003-05-1597
  6. Knox KK, 1996, Clin Infect Dis, 22, 174, 10.1093/clinids/22.1.174 · doi:10.1093/clinids/22.1.174
  7. Tsujimura H, 1998, Eur J Haematol, 61, 284, 10.1111/j.1600-0609.1998.tb01718.x · doi:10.1111/j.1600-0609.1998.tb01718.x
  8. Tiacci E, 2000, Haematologica, 85, 94
  9. 10.1016/0166-0934(95)02002-0 · doi:10.1016/0166-0934(95)02002-0
  10. Burns WH, 1990, J Infect Dis, 162, 634, 10.1093/infdis/162.3.634 · doi:10.1093/infdis/162.3.634
  11. 10.1038/sj.bmt.1703153 · doi:10.1038/sj.bmt.1703153

Cited by

See all 338

Metadata

Authors
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M.
Venue
Clinical Infectious Diseases
Published
2005-04
Volume
40
Issue
7
Pages
932-940
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2120032553
Cited by
338
References
29
FWCI
13.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. https://app.cochat.ai/papers/10.1086/428060
The paper
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M. (2005). Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases. https://doi.org/10.1086/428060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.